Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02034552
Title A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Scottsdale Arizona 85251 United States Details
Tucson Arizona 85704 United States Details
Los Angeles California 90033 United States Details
New Haven Connecticut 06520 United States Details
Newark Delaware 19713 United States Details
Washington District of Columbia 20007 United States Details
Plantation Florida 33324 United States Details
Indianapolis Indiana 46202 United States Details
New Orleans Louisiana 70112 United States Details
Shreveport Louisiana 71103 United States Details
Rockville Maryland 20850 United States Details
Detroit Michigan 48201 United States Details
Saint Louis Missouri 63110 United States Details
Omaha Nebraska 68130 United States Details
Bronx New York 10467-2490 United States Details
Syracuse New York 13210 United States Details
Springfield Oregon 97477 United States Details
Houston Texas 77027 United States Details
Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field